ABC adherence and impact of optimal medical therapy in heart failure patients with atrial fibrillation

26 August 2022 (08:00 - 19:30)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Niccolo Bonini

Modena Polyclinic Modena University Hospital, Modena (Italy)

6 More presentations in this session

Presentation thumbnail

Type III collagen formation is significantly associated with risk of outcome in HFpEF patients but loses its significant association with underlying AF

Ms E. Angeli (Copenhagen, DK)

Abstract Slides

Presentation thumbnail

Baseline profile and results of atrial fibrillation ablation in patients with arrhythmia-induced cardiomyopathy

Ms T. Gonzalez Ferrero (Madrid, ES)

Abstract Slides

Presentation thumbnail

Aggressive combined pharmacotherapy for heart failure reduces new onset atrial fibrillation

Doctor M. Tokutome (Fukuoka, JP)

Abstract Slides

Presentation thumbnail

Association of beta blocker use with new-onset heart failure and mortality in atrial fibrillation without pre-existing heart failure: the Fushimi AF registry

Doctor M. Akao (Kyoto, JP) Doctor M. Iguchi (Kyoto, JP)

Abstract Slides

Presentation thumbnail

Survival among people with heart failure and atrial fibrillation; a population cohort study

Doctor N. Jones (Oxford, GB)

Abstract Slides

Access the full session

Session thumbnail

Chronic heart failure and atrial fibrillation

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

You may be interested in

Congress Presentation

Breaking the barriers in guideline-directed medical therapy implementation in heart failure - discussion

Congress Presentation

The role of ICD therapy in heart failure in 2024. What is the holistic approach to treat heart failure?

Congress Session

Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources